StonvexLoading…
StonvexStonvexStonvexCore line items from KEX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $844.10M | $3.36B | $2.51B | $1.64B |
Operating Income | $107.67M | $496.28M | $366.61M | $237.39M |
Net Income | $81.20M | $354.57M | $262.76M | $170.26M |
EPS (Diluted) | $1.50 | $6.33 | $4.64 | $2.99 |
Total Assets | $6.12B | $6.01B | $6.06B | $6.08B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $58.01M | $78.78M | $47.02M | $68.38M |
Free Cash Flow OCF − CapEx | $49.39M | $405.73M | $140.55M | $-19.70M |
Shares Outstanding | 54.01M | 56.05M | 56.56M | 56.87M |